535 related articles for article (PubMed ID: 26448933)
1. Efficient Mitochondrial Genome Editing by CRISPR/Cas9.
Jo A; Ham S; Lee GH; Lee YI; Kim S; Lee YS; Shin JH; Lee Y
Biomed Res Int; 2015; 2015():305716. PubMed ID: 26448933
[TBL] [Abstract][Full Text] [Related]
2. Knock-In Strategy for Editing Human and Zebrafish Mitochondrial DNA Using Mito-CRISPR/Cas9 System.
Bian WP; Chen YL; Luo JJ; Wang C; Xie SL; Pei DS
ACS Synth Biol; 2019 Apr; 8(4):621-632. PubMed ID: 30955321
[TBL] [Abstract][Full Text] [Related]
3. RNA-guided genome editing in plants using a CRISPR-Cas system.
Xie K; Yang Y
Mol Plant; 2013 Nov; 6(6):1975-83. PubMed ID: 23956122
[TBL] [Abstract][Full Text] [Related]
4. CRISPR/Cas9-Based Genome Editing for Disease Modeling and Therapy: Challenges and Opportunities for Nonviral Delivery.
Wang HX; Li M; Lee CM; Chakraborty S; Kim HW; Bao G; Leong KW
Chem Rev; 2017 Aug; 117(15):9874-9906. PubMed ID: 28640612
[TBL] [Abstract][Full Text] [Related]
5. CRISPR/Cas9-mediated mutagenesis at microhomologous regions of human mitochondrial genome.
Wang B; Lv X; Wang Y; Wang Z; Liu Q; Lu B; Liu Y; Gu F
Sci China Life Sci; 2021 Sep; 64(9):1463-1472. PubMed ID: 33420919
[TBL] [Abstract][Full Text] [Related]
6. Edition of TFAM gene by CRISPR/Cas9 technology in bovine model.
de Oliveira VC; Moreira GSA; Bressan FF; Gomes Mariano Junior C; Roballo KCS; Charpentier M; Concordet JP; Meirelles FV; Ambrósio CE
PLoS One; 2019; 14(3):e0213376. PubMed ID: 30845180
[TBL] [Abstract][Full Text] [Related]
7. Chromatin accessibility and guide sequence secondary structure affect CRISPR-Cas9 gene editing efficiency.
Jensen KT; Fløe L; Petersen TS; Huang J; Xu F; Bolund L; Luo Y; Lin L
FEBS Lett; 2017 Jul; 591(13):1892-1901. PubMed ID: 28580607
[TBL] [Abstract][Full Text] [Related]
8. Site-specific CRISPR-based mitochondrial DNA manipulation is limited by gRNA import.
Schmiderer L; Yudovich D; Oburoglu L; Hjort M; Larsson J
Sci Rep; 2022 Nov; 12(1):18687. PubMed ID: 36333335
[TBL] [Abstract][Full Text] [Related]
9. Production of knockout mice by DNA microinjection of various CRISPR/Cas9 vectors into freeze-thawed fertilized oocytes.
Nakagawa Y; Sakuma T; Sakamoto T; Ohmuraya M; Nakagata N; Yamamoto T
BMC Biotechnol; 2015 May; 15():33. PubMed ID: 25997509
[TBL] [Abstract][Full Text] [Related]
10. CRISPR/Cas9 for genome editing: progress, implications and challenges.
Zhang F; Wen Y; Guo X
Hum Mol Genet; 2014 Sep; 23(R1):R40-6. PubMed ID: 24651067
[TBL] [Abstract][Full Text] [Related]
11. Harnessing CRISPR-Cas systems for bacterial genome editing.
Selle K; Barrangou R
Trends Microbiol; 2015 Apr; 23(4):225-32. PubMed ID: 25698413
[TBL] [Abstract][Full Text] [Related]
12. Mitochondrial import, health and mtDNA copy number variability seen when using type II and type V CRISPR effectors.
Antón Z; Mullally G; Ford HC; van der Kamp MW; Szczelkun MD; Lane JD
J Cell Sci; 2020 Sep; 133(18):. PubMed ID: 32843580
[TBL] [Abstract][Full Text] [Related]
13. [The application of CRISPR-Cas9 gene editing technology in viral infection diseases].
Yin LJ; Hu SQ; Guo F
Yi Chuan; 2015 May; 37(5):412-8. PubMed ID: 25998428
[TBL] [Abstract][Full Text] [Related]
14. Genome modification by CRISPR/Cas9.
Ma Y; Zhang L; Huang X
FEBS J; 2014 Dec; 281(23):5186-93. PubMed ID: 25315507
[TBL] [Abstract][Full Text] [Related]
15. Selection and Validation of Spacer Sequences for CRISPR-Cas9 Genome Editing and Transcription Regulation in Bacteria.
Grenier F; Lucier JF; Rodrigue S
Methods Mol Biol; 2015; 1334():233-44. PubMed ID: 26404154
[TBL] [Abstract][Full Text] [Related]
16. Recent Progress in CRISPR/Cas9 Technology.
Mei Y; Wang Y; Chen H; Sun ZS; Ju XD
J Genet Genomics; 2016 Feb; 43(2):63-75. PubMed ID: 26924689
[TBL] [Abstract][Full Text] [Related]
17. CRISPR/Cas9-mediated genome engineering: an adeno-associated viral (AAV) vector toolbox.
Senís E; Fatouros C; Große S; Wiedtke E; Niopek D; Mueller AK; Börner K; Grimm D
Biotechnol J; 2014 Nov; 9(11):1402-12. PubMed ID: 25186301
[TBL] [Abstract][Full Text] [Related]
18. CRISPR/Cas9-mediated genome engineering of CHO cell factories: Application and perspectives.
Lee JS; Grav LM; Lewis NE; Faustrup Kildegaard H
Biotechnol J; 2015 Jul; 10(7):979-94. PubMed ID: 26058577
[TBL] [Abstract][Full Text] [Related]
19. Dual sgRNAs facilitate CRISPR/Cas9-mediated mouse genome targeting.
Zhou J; Wang J; Shen B; Chen L; Su Y; Yang J; Zhang W; Tian X; Huang X
FEBS J; 2014 Apr; 281(7):1717-25. PubMed ID: 24494965
[TBL] [Abstract][Full Text] [Related]
20. Application of CRISPR/Cas9 genome editing to the study and treatment of disease.
Pellagatti A; Dolatshad H; Valletta S; Boultwood J
Arch Toxicol; 2015 Jul; 89(7):1023-34. PubMed ID: 25827103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
